Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles
Claudio Cabello-Verrugio*, María Gabriela Morales, Daniel Cabrera, Carlos P. Vio, Enrique Brandan
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
78Scopus
citations
Fingerprint
Dive into the research topics of 'Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles'. Together they form a unique fingerprint.